Article content continued If we can manage to control COVID, we should be able to control influenza activity According to the report for the week that ended Oct. 31, only one of the 40 or so regions it designates across country was reporting any flu — those eight cases — and there were no outbreaks.… Read More »
Amid daily headlines about COVID-19 vaccines and trends, Gilead’s Veklury, also known as remdesivir, remains the only antiviral drug authorized to treat the illness. With a new move from the FDA, the medicine’s emergency green light is a little broader—despite some lingering questions about its efficacy. Under the expanded emergency use authorization (EUA), all hospitalized… Read More »
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. A shocking graphic video posted on Twitter this week shows conditions in Asian “wet markets” haven’t changed despite a coronavirus pandemic that has killed more than 307,000 people worldwide. The images, posted by PETA Asia, show pigs, frogs, eels,… Read More »
Dive Brief: Even without the Affordable Care Act’s individual mandate penalty, the individual market last year was stable and profitable for payers, according to a new analysis from the Kaiser Family Foundation. Overall enrollment in the individual market fell by a modest 5% and premiums were mostly steady. Medical loss ratios for the third quarter… Read More »